Materiały źródłowe

• #1 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] This activity reviews the causes of DVT and highlights the role of the interprofessional team in the prophylaxis against DVT. […] Develop strategies to increase compliance with the use of DVT prophylaxis. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT. […] Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient.

• #2 Venous thromboembolism (VTE) prophylaxis – Symptoms, diagnosis and treatment | BMJ Best Practice US

  https://bestpractice.bmj.com/topics/en-us/1087

  Thromboprophylaxis is the most important patient safety strategy in patients admitted to the hospital. […] Although national and international thromboprophylaxis guidelines have repeatedly recommended thromboprophylaxis of patients admitted to the hospital, only 40% to 50% of medical patients and 60% to 75% of surgical patients receive adequate thromboprophylaxis. […] Venous thromboembolism (VTE) prophylaxis consists of pharmacologic and nonpharmacologic measures to diminish the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE).

• #3 Venous thromboembolism (VTE) prophylaxis – Symptoms, diagnosis and treatment | BMJ Best Practice

  https://bestpractice.bmj.com/topics/en-gb/1087

  Thromboprophylaxis is the most important patient safety strategy in patients admitted to hospital. […] Although national and international thromboprophylaxis guidelines have repeatedly recommended thromboprophylaxis of patients admitted to hospital, only 40% to 50% of medical patients and 60% to 75% of surgical patients receive adequate thromboprophylaxis. […] Venous thromboembolism (VTE) prophylaxis consists of pharmacological and non-pharmacological measures to diminish the risk of deep vein thrombosis (DVT) and pulmonary embolism (PE). […] DVT of the leg is the development of a blood clot in one of the major deep veins in the leg or thigh, which leads to impaired venous blood flow, usually causing leg swelling and pain. […] About 51% of deep venous thrombi will embolise to the pulmonary vasculature, resulting in a PE.

• #4 Venous Thromboembolism Prophylaxis | eCQI Resource Center

  https://ecqi.healthit.gov/ecqm/eh/2024/cms0108v12

  Despite its proven effectiveness, VTE prophylaxis remains underused or inappropriately used in both medical and surgical patients (Kahn et al., 2018). […] Failure to recognize and protect patients at risk for venous thromboembolism (VTE) increases the chances for acutely ill hospitalized patients at high risk for developing a deep vein thrombosis or dying from a pulmonary embolism. Screening all patients is the only evidence-based practice in reducing incidence of disease. All hospitalized patients should be evaluated for primary VTE prophylaxis, and given appropriate prophylaxis when indicated.

• #5 Deep Venous Thrombosis Prophylaxis | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/20299

  Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT. […] Hospitalized patients are at increased risk of developing DVT (approximately 50%), increasing the risk of PE. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE.

• #6 Venous Thromboembolism Prophylaxis

  https://ecqi.healthit.gov/sites/default/files/ecqm/measures/CMS108v6.html

  In a review of evidence-based patient safety practices, the Agency for Healthcare Research and Quality defined thromboprophylaxis against VTE as the „number one patient safety practice” for hospitalized patients (Shojania, 2001). […] Updated „safe practices” published by the National Quality Forum (NQF) recommend routine evaluation of hospitalized patients for risk of VTE and use of appropriate prophylaxis (National Quality Forum. National Voluntary Consensus Standards for Prevention and Care of Venous Thromboembolism, 2006). […] As noted by the ACCP, a vast number of randomized clinical trials provide irrefutable evidence that thromboprophylaxis reduces VTE events, and there are studies that have also shown that fatal PE is prevented by thromboprophylaxis (Geerts, et al. 2008). […] All hospitalized patients should be evaluated for primary VTE prophylaxis, and given appropriate prophylaxis when indicated.

• #7 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE. […] Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises.

• #8 Deep Venous Thrombosis Prophylaxis | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/20299

  Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] Prevention of DVT thereby decreases the incidence of PE, a serious and life-threatening condition. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT. […] Hospitalized patients are at increased risk of developing DVT (approximately 50%), increasing the risk of PE. […] Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE.

• #9 Deep Venous Thrombosis Prophylaxis (DVT Prophylaxis) – MD Searchlight

  https://mdsearchlight.com/preventive-medicine/deep-venous-thrombosis-prophylaxis-dvt-prophylaxis/

  Deep vein thrombosis (DVT) is the medical term for a blood clot that forms in the deeper veins of your body, mostly in the legs. Preventing DVT is important because it can stop PE, which can be very severe and even lethal. DVT is a major cause of illness and death that can be avoided globally. In the United States, DVT and PE cause between 60,000 and 100,000 deaths every year. Patients in the hospital are at higher risk of getting DVT as they often have to stay still for long periods, and for other reasons. Thats why doctors often provide these patients with DVT prophylaxis treatments to help prevent DVT. There are two main ways to do this: mechanical methods that help blood flow better, and drugs that make your blood less prone to clotting. Providing these treatments to patients in the hospital can significantly reduce the chances of DVT and PE, leading to better patient outcomes overall. This prevention can either be primary (preferred), which uses medications and mechanical methods to avoid DVT from happening, or secondary, which is less common and involves early detection and treatment when DVT has already begun, but is not yet causing symptoms. Proactive measures to prevent these clots, or deep vein thrombosis (DVT) prophylaxis, should be considered for every patient staying in a hospital. To decide the best preventive measures, patients at risk of developing clots (thrombosis) are categorized into three groups: Low-risk patients: Young individuals without any risk factors for clot formation. They usually dont need preventive measures. Moderate-risk patients: Patients with at least one risk factor. Regular medication, sometimes combined with mechanical preventive measures, is often recommended to prevent clot formation. High-risk patients: Patients with several risk factors. Medication in combination with mechanical measures is the preferred preventive option. Various drugs are commonly used to prevent clots in hospitalized patients and include low-molecular-weight heparins (LMWH), unfractionated heparin (UFH), and fondaparinux. Direct oral anticoagulants, a new type of blood thinner, have also been shown to reduce death rates among hospitalized patients, with betrixaban and rivaroxaban being approved for use in the hospital setting. Patients deemed at risk for developing clots yet also at high risk for bleeding may require mechanical measures, which include the use of devices like intermittent pneumatic compression, graduated compression stockings, and venous foot pump. Long-distance travelers who have a risk of VTE are recommended to wear properly fitted, below-knee compression stockings that apply 15-30 mm Hg of pressure. They are also advised to regularly stand and move around during the trip. A person should not get Deep Venous Thrombosis (DVT) prophylaxis if they are currently bleeding, have a blood clotting disorder, are scheduled for surgery in the next 6 to 12 hours, have low blood platelets, have a bleeding disorder, have peripheral vascular disease, or have broken down and non-healable skin. Taking preventative medicines can sometimes lead to side effects, including disturbed kidney function, bleeding, and heparin-induced thrombocytopenia (HIT). DVT prophylaxis can decrease the chances of getting DVT by 10 to 80%.

• #10 Venous thromboembolism (VTE) prophylaxis – Symptoms, diagnosis and treatment | BMJ Best Practice

  https://bestpractice.bmj.com/topics/en-gb/1087

  Risk factors include previous VTE (deep vein thrombosis [DVT] and/or pulmonary embolism [PE]), thrombophilia, malignancy, postoperative setting, trauma, indwelling central catheter, immobility, and increasing age. […] National Institute for Health and Care Excellence. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism.

• #11 11 Tips for DVT Prevention – Preferred Vascular Group

  https://preferredvasculargroup.com/dvt-prevention-tips/

  Deep vein thrombosis (DVT) is a condition in which a blood clot forms in one of the deep veins of your body. To decrease your risk of developing a blood clot in a deep vein, follow these tips for DVT prevention. One of the best tips for DVT prevention is to know whether or not you are at risk for the condition. The following factors can increase the chances of DVT: Surgery, Trauma, Sitting for long periods of time, Blood clotting disorder, Obesity, Pregnancy the first 4-6 weeks after giving birth, Varicose veins, Smoking, Heart failure, Inflammatory bowel disease, Increasing age, Kidney disease, Cancer and cancer therapy, Hormone therapy (birth control, hormone replacement), A pacemaker or a tube in a vein, History of DVT. Many of us sit at desks all day for work, which can increase the risk of deep vein thrombosis. If you do work in an office setting, try to find ways to keep moving throughout the day. Take frequent breaks to walk around the building or go up and down the stairs. Being overweight or obese increases your risk of DVT. Thats why losing weight and maintaining a healthy weight is a good DVT prevention tip. Smoking is bad for almost every aspect of your health, and that includes your vascular health. Quitting smoking is one of the best things you can do for your health. You should definitely make a point of moving throughout the day, but just walking around your office building or taking the stairs isnt really sufficient exercise. According to the Mayo Clinic, you should get about 2.5 hours of moderate-intensity aerobic exercise every week. If youre driving a long distance, youll be sitting for an extended period. And thats a no-no for preventing DVT. The solution is to stop every two hours to get out and move around. Compression garments can be worn to help prevent blood clots. Compression stockings or leggings can help prevent DVT. Staying hydrated at all times is a good DVT prevention tip. Aside from the compression stockings mentioned above, wear loose clothing that isnt constricting. If you have any of the conditions listed above that increase your risk of DVT, then make sure you are working with your doctors to manage them. If youre at a high risk of developing deep vein thrombosis, talk to your doctor about steps you can take to prevent it.

• #12 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Deep vein thrombosis (DVT) is the formation or presence of a thrombus in the deep veins. […] This activity reviews the causes of DVT and highlights the role of the interprofessional team in the prophylaxis against DVT. […] Develop strategies to increase compliance with the use of DVT prophylaxis. […] DVT prophylaxis targets either venous stasis (mechanical methods) or hypercoagulability (pharmacological prophylaxis). […] Only 50% of hospitalized patients receive DVT prophylaxis. Prevention of DVT in hospitalized patients decreases the risk of DVT and PE, decreasing mortality and morbidity. […] DVT prophylaxis can be primary or secondary. Primary prophylaxis is preferred, using medications and mechanical methods to prevent DVT. […] Hospitalized patients are at increased risk of VTE when compared to patients in the community. Therefore, DVT prophylaxis should be considered in every hospitalized patient.

• #13 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention

  It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation (eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant), and intermittent pneumatic compression. Patients at higher risk of DVT include those undergoing minor surgery if they have clinical risk factors for DVT; those undergoing major surgery, especially orthopedic surgery, even without risk factors; and bedbound patients with major medical illnesses. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy (eg, compression devices or stockings, venous filters) and pharmacologic therapy (including low-dose unfractionated heparin, low molecular weight heparins, warfarin, fondaparinux, direct oral anticoagulants). The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The role of aspirin for DVT prophylaxis is largely limited to patients undergoing total hip or knee replacement surgery. Low-dose unfractionated heparin (UFH) is given 2 hours before surgery and every 8 to 12 hours thereafter for 7 to 10 days or until patients are fully ambulatory. LMWHs are more effective than low-dose UFH for preventing DVT and PE, but widespread use is limited by cost. Direct oral anticoagulants are at least as effective and safe as LMWH for preventing DVT and PE after hip or knee replacement surgery but are more expensive than warfarin. With DVT prophylaxis, there is always a risk of bleeding during use of anticoagulants. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment may be started before or after surgery and continued for at least 14 days. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.

• #14 Preventing deep vein thrombosis in hospital inpatients

  https://pmc.ncbi.nlm.nih.gov/articles/PMC1925160/

  Methods of DVT prophylaxis include general measures: the use of aspirin, mechanical prevention with graduated compression stockings, and intermittent pneumatic compression devices […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network support ambulation for all patients if possible, and recommend LMWH or UFH for medical patients with heart failure or respiratory disease or with substantial immobility plus additional risk factors for DVT […] Mechanical prophylaxis may be considered in all immobile patients and should be used for those who cannot receive anticoagulants […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network recommend early mobilisation for general surgery patients at low risk of DVT; UFH or LMWH for patients with risk factors for DVT (including age), and the addition of mechanical prophylaxis to LMWH or UFH for those with multiple risk factors for DVT

• #15 Thrombosis prevention – Wikipedia

  https://en.wikipedia.org/wiki/Thrombosis_prevention

  Thrombosis prophylaxis is effective in preventing the formation of blood clots, their lodging in the veins, and their developing into thromboemboli that can travel through the circulatory system to cause blockage and subsequent tissue death in other organs. […] The Centers for Disease Control and Prevention recommend the following: Move around as soon as possible after being confined to bed, such as after surgery, illness, or injury. […] If you’re at risk for DVT, talk to your doctor about: Graduated compression stockings (sometimes called „medical compression stockings”) […] Medication (anticoagulants) to prevent DVT. […] The application of antiembolism stockings can be used to prevent thrombosis. […] Adding heparin to the use of compression stockings may prevent thrombosis for those at higher risk.

• #16 dvt prophylaxis | PPT

  https://www.slideshare.net/slideshow/dvt-prophylaxis-51464046/51464046

  This document discusses deep vein thrombosis (DVT) prophylaxis. It defines DVT as clot formation in the deep veins of the legs, with an annual incidence of 1-2 per 1000 people in the US. […] Prophylaxis includes mechanical methods, aspirin, anticoagulants, and stratified prophylaxis based on patient risk factors. […] Prophylaxis Mechanical compression stockings intermittent pneumatic compression devices ivc filters […] Pharmacological 1. Platelet Active Drugs {aspirin 50-100mg/d} 2. Courmarins {Warfarin} 3. Heparins (UFH) 4. Low Molecular Weight Heparins (LMWH) {Enoxaparin} 5. Factor Xa Inhibitors {Rivaroxaban} […] DVT Prophylaxis Based on Risk Stratification Levels […] Risk Group Classification for Orthopaedic Patients […] Low Risk Patients; no specific prophylaxis is required other than early and aggressive mobilisation Moderate Risk Patients; low dose UFH {LDUF q12hrs}, LMWH {3,400 U qd}, and IPC High Risk Patients; low dose UFH q8h, LMWH {3400 U qd}, with or without IPC Very High Risk Patients; LMWH {3400 U qd}, fondaparinux, and coumarins (INR 2-3).

• #17 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE. […] Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises.

• #18 Preventing deep vein thrombosis in hospital inpatients

  https://pmc.ncbi.nlm.nih.gov/articles/PMC1925160/

  Methods of DVT prophylaxis include general measures: the use of aspirin, mechanical prevention with graduated compression stockings, and intermittent pneumatic compression devices […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network support ambulation for all patients if possible, and recommend LMWH or UFH for medical patients with heart failure or respiratory disease or with substantial immobility plus additional risk factors for DVT […] Mechanical prophylaxis may be considered in all immobile patients and should be used for those who cannot receive anticoagulants […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network recommend early mobilisation for general surgery patients at low risk of DVT; UFH or LMWH for patients with risk factors for DVT (including age), and the addition of mechanical prophylaxis to LMWH or UFH for those with multiple risk factors for DVT

• #19 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE. […] Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises.

• #20 Deep Vein Thrombosis and Pulmonary Embolism | Yellow Book | CDC

  https://wwwnc.cdc.gov/travel/yellowbook/2024/air-land-sea/deep-vein-thrombosis-and-pulmonary-embolism

  The American College of Chest Physicians (ACCP) and the American Society of Hematology (ASH) each provide guidelines on the prevention of VTE in long-distance travelers. […] For long-distance travelers (6 hours travel) at increased risk of VTE, the ACCP recommends frequent ambulation, calf muscle exercise, sitting in an aisle seat, and using properly fitted below-the-knee GCS that provide 15-30 mmHg of pressure at the ankle during travel. […] For long-distance travelers (4 hours travel) at substantially increased VTE risk (e.g., recent surgery, prior history of VTE, postpartum, active malignancy, or 2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guidelines suggest GCS or prophylactic LMWH.

• #21 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE. […] Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises.

• #22 Deep Venous Thrombosis Prophylaxis | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/20299

  Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE. […] Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises. […] VTE risk is high in patients undergoing major orthopedic surgeries like knee or hip surgeries.

• #23 List of 14 Deep Vein Thrombosis, Prophylaxis Medications Compared

  https://www.drugs.com/condition/deep-vein-thrombosis-prophylaxis.html

  Pharmacological and non-pharmacological measures taken to prevent blood from clotting in the veins […] The medications listed below are related to or used in the treatment of this condition. […] for enoxaparin to treat Deep Vein Thrombosis, Prophylaxis […] for Xarelto to treat Deep Vein Thrombosis, Prophylaxis […] for Lovenox to treat Deep Vein Thrombosis, Prophylaxis […] for Eliquis to treat Deep Vein Thrombosis, Prophylaxis […] for heparin to treat Deep Vein Thrombosis, Prophylaxis […] for rivaroxaban to treat Deep Vein Thrombosis, Prophylaxis […] for apixaban to treat Deep Vein Thrombosis, Prophylaxis […] for Arixtra to treat Deep Vein Thrombosis, Prophylaxis […] for fondaparinux to treat Deep Vein Thrombosis, Prophylaxis […] for Fragmin to treat Deep Vein Thrombosis, Prophylaxis

• #24 Deep Vein Thrombosis Prevention

  https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm

  Early mobilization after surgery is critical […] Most non-surgical patients do not require DVT Prophylaxis after discharge (unless VTE or other indication) […] Anticoagulation start varies per medication and risk […] Continue Anticoagulation for at least 10 to 14 days post-orthopedic surgery […] Indications for extended Anticoagulation (28-35 days) […] Anticoagulation options […] Low Molecular Weight Heparin […] Warfarin with target INR 2-3 […] Aspirin (not a first-line agent) […] However, Low Molecular Weight Heparin is much more effective […] Additional strategies (with Anticoagulation) […] Duration of DVT Prophylaxis (may be adjusted for mobility) […] Low Molecular Weight Heparin (e.g. Enoxaparin or Lovenox) […] Compared with LMWH, Apixaban has equivalent efficacy in DVT Prophylaxis

• #25 Venous Thromboembolism Prophylaxis | eCQI Resource Center

  https://ecqi.healthit.gov/ecqm/eh/2024/cms0108v12

  This measure assesses the number of patients who received Venous Thromboembolism (VTE) prophylaxis or have documentation why no VTE prophylaxis was given between the day of arrival to the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. […] American Society of Hematology (ASH) 2018 VTE prophylaxis guidelines strongly recommend pharmacological prophylaxis using unfractionated heparin (UFH), low molecular weight heparin (LMWH) or fondaparinux for acutely and critically ill hospitalized medical patients, unless contraindicated. The use of mechanical prophylaxis is an acceptable alternative for patients with increased risk of bleeding and preferred over no prophylaxis. ASH 2019 guidelines for surgical patients similarly recommend pharmacological or mechanical prophylaxis over no VTE prophylaxis.

• #26 Venous Thromboembolism Prophylaxis | eCQI Resource Center

  https://ecqi.healthit.gov/ecqm/eh/2024/cms0108v12

  This measure assesses the number of patients who received Venous Thromboembolism (VTE) prophylaxis or have documentation why no VTE prophylaxis was given between the day of arrival to the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. […] American Society of Hematology (ASH) 2018 VTE prophylaxis guidelines strongly recommend pharmacological prophylaxis using unfractionated heparin (UFH), low molecular weight heparin (LMWH) or fondaparinux for acutely and critically ill hospitalized medical patients, unless contraindicated. The use of mechanical prophylaxis is an acceptable alternative for patients with increased risk of bleeding and preferred over no prophylaxis. ASH 2019 guidelines for surgical patients similarly recommend pharmacological or mechanical prophylaxis over no VTE prophylaxis.

• #27 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention

  It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation (eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant), and intermittent pneumatic compression. Patients at higher risk of DVT include those undergoing minor surgery if they have clinical risk factors for DVT; those undergoing major surgery, especially orthopedic surgery, even without risk factors; and bedbound patients with major medical illnesses. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy (eg, compression devices or stockings, venous filters) and pharmacologic therapy (including low-dose unfractionated heparin, low molecular weight heparins, warfarin, fondaparinux, direct oral anticoagulants). The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The role of aspirin for DVT prophylaxis is largely limited to patients undergoing total hip or knee replacement surgery. Low-dose unfractionated heparin (UFH) is given 2 hours before surgery and every 8 to 12 hours thereafter for 7 to 10 days or until patients are fully ambulatory. LMWHs are more effective than low-dose UFH for preventing DVT and PE, but widespread use is limited by cost. Direct oral anticoagulants are at least as effective and safe as LMWH for preventing DVT and PE after hip or knee replacement surgery but are more expensive than warfarin. With DVT prophylaxis, there is always a risk of bleeding during use of anticoagulants. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment may be started before or after surgery and continued for at least 14 days. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.

• #28 Deep Vein Thrombosis Prevention

  https://fpnotebook.com/HemeOnc/Prevent/DpVnThrmbsPrvntn.htm

  Early mobilization after surgery is critical […] Most non-surgical patients do not require DVT Prophylaxis after discharge (unless VTE or other indication) […] Anticoagulation start varies per medication and risk […] Continue Anticoagulation for at least 10 to 14 days post-orthopedic surgery […] Indications for extended Anticoagulation (28-35 days) […] Anticoagulation options […] Low Molecular Weight Heparin […] Warfarin with target INR 2-3 […] Aspirin (not a first-line agent) […] However, Low Molecular Weight Heparin is much more effective […] Additional strategies (with Anticoagulation) […] Duration of DVT Prophylaxis (may be adjusted for mobility) […] Low Molecular Weight Heparin (e.g. Enoxaparin or Lovenox) […] Compared with LMWH, Apixaban has equivalent efficacy in DVT Prophylaxis

• #29 Preventing deep vein thrombosis in hospital inpatients

  https://pmc.ncbi.nlm.nih.gov/articles/PMC1925160/

  NICE recommends mechanical prophylaxis for all patients, with the addition of LMWH for those with one or more risk factors for DVT […] Appropriate use of DVT prophylaxis in hospital inpatients is important for reducing the risk of post-thrombotic complications as well as fatal and non-fatal pulmonary embolism […] For patients at low risk of DVT, ambulation is important, and mechanical methods of prophylaxis can provide added protection […] Patients at higher risk of DVT should be considered for guideline based anticoagulation with LMWH, UFH, or vitamin K antagonists unless clearly contraindicated […] The place of aspirin in DVT prophylaxis remains controversial.

• #30 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention

  It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation (eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant), and intermittent pneumatic compression. Patients at higher risk of DVT include those undergoing minor surgery if they have clinical risk factors for DVT; those undergoing major surgery, especially orthopedic surgery, even without risk factors; and bedbound patients with major medical illnesses. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy (eg, compression devices or stockings, venous filters) and pharmacologic therapy (including low-dose unfractionated heparin, low molecular weight heparins, warfarin, fondaparinux, direct oral anticoagulants). The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The role of aspirin for DVT prophylaxis is largely limited to patients undergoing total hip or knee replacement surgery. Low-dose unfractionated heparin (UFH) is given 2 hours before surgery and every 8 to 12 hours thereafter for 7 to 10 days or until patients are fully ambulatory. LMWHs are more effective than low-dose UFH for preventing DVT and PE, but widespread use is limited by cost. Direct oral anticoagulants are at least as effective and safe as LMWH for preventing DVT and PE after hip or knee replacement surgery but are more expensive than warfarin. With DVT prophylaxis, there is always a risk of bleeding during use of anticoagulants. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment may be started before or after surgery and continued for at least 14 days. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.

• #31 Preventing deep vein thrombosis in hospital inpatients

  https://pmc.ncbi.nlm.nih.gov/articles/PMC1925160/

  Methods of DVT prophylaxis include general measures: the use of aspirin, mechanical prevention with graduated compression stockings, and intermittent pneumatic compression devices […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network support ambulation for all patients if possible, and recommend LMWH or UFH for medical patients with heart failure or respiratory disease or with substantial immobility plus additional risk factors for DVT […] Mechanical prophylaxis may be considered in all immobile patients and should be used for those who cannot receive anticoagulants […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network recommend early mobilisation for general surgery patients at low risk of DVT; UFH or LMWH for patients with risk factors for DVT (including age), and the addition of mechanical prophylaxis to LMWH or UFH for those with multiple risk factors for DVT

• #32 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods

  https://emedicine.medscape.com/article/1268573-overview

  Many pharmacologic agents are currently available to prevent thrombosis. […] In a systematic review and meta-analysis (61 studies) evaluating the efficacy of 11 anticoagulants for preventing VTE after total hip arthroplasty (THA) or total knee arthroplasty (TKA), Huang et al found apixaban, edoxaban, fondaparinux, rivaroxaban, and darexaban to be the most efficacious agents. […] The use of a checklist to stratify patients and assign them to categories of relative propensity for DVT development is helpful in deciding on an appropriate treatment regimen. […] In August 2024, updated European guidelines on perioperative prophylaxis of VTE in patients undergoing nonambulatory orthopedic surgery were published. […] Recommendations included the following: For patients undergoing low-VTE-risk procedures who do not have a personal high-risk factor for VTE, no pharmacologic VTE prophylaxis is suggested.

• #33 Prevention of Venous Thromboembolism | Doctor

  https://patient.info/doctor/prevention-of-venous-thromboembolism

  Patients with high risk and those having orthopaedic surgery should also be offered LMWH. Fondaparinux, within its licensed indications, is an effective and safe alternative. […] […] Patients should be encouraged to maintain their fluid intake and not become dehydrated during their stay in hospital. […] […] Prophylactic IVC filters are sometimes inserted in patients at high risk of developing venous thromboembolism, especially if there is a contraindication to anticoagulation. […] […] Patients having hip replacement, surgical treatment of hip fractures and other kinds of major orthopaedic surgery should be offered mechanical and pharmacological prophylaxis. Otherwise, only mechanical prophylaxis is required. […] […] If pharmacological VTE prophylaxis is indicated, start as soon as possible after risk assessment. Always also consider the risk of bleeding. […]

• #34 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  VTE risk is high in patients undergoing major orthopedic surgeries like knee or hip surgeries. […] Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] Pharmacological prophylaxis is considered in individual cases, particularly in those with the following risk factors: A prior history of VTE, Hospitalization for an acute illness or cesarean delivery, The presence of an inherited thrombophilia. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.

• #35 Deep Venous Thrombosis Prophylaxis | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/20299

  Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] Patients undergoing isolated lower extremity orthopedic surgery requiring immobilization do not require DVT prophylaxis as long as they can ambulate early and adequately. […] Major surgeries are categorized as moderate to high risk for VTE and need DVT prophylaxis. […] Antepartum pharmacological prophylaxis is continued throughout the pregnancy. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] The complications from pharmacological prophylaxis include: Disturbed renal function, Bleeding, Heparin-induced thrombocytopenia (HIT). […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients.

• #36 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods

  https://emedicine.medscape.com/article/1268573-overview

  Venous thromboembolism (VTE, including deep vein thrombosis [DVT] and pulmonary embolism [PE]) in surgical patients undergoing general anesthesia has been extensively studied. The risk of VTE remains high for up to 2 months after noncancer general surgery. […] The ninth edition of the clinical practice guidelines for prevention of VTE from the American College of Chest Physicians (ACCP) recommended that LMWH be given to patients undergoing major orthopedic procedures at least 12 hours preoperatively or postoperatively. […] In August 2024, updated European guidelines for prophylaxis of VTE in nonambulatory orthopedic surgery were published. […] Mechanical methods have been shown to be a useful adjunct to anticoagulation therapy in reducing the incidence of DVT. […] Although all three types of mechanical compression reduce the incidence of DVT to less than that found when prophylaxis is absent, these modalities are generally less effective at producing such reductions than pharmacologic methods are.

• #37 Deep Venous Thrombosis Prophylaxis in Orthopedic Surgery: Background, Mechanical Methods, Pharmacologic Methods

  https://emedicine.medscape.com/article/1268573-overview

  Many pharmacologic agents are currently available to prevent thrombosis. […] In a systematic review and meta-analysis (61 studies) evaluating the efficacy of 11 anticoagulants for preventing VTE after total hip arthroplasty (THA) or total knee arthroplasty (TKA), Huang et al found apixaban, edoxaban, fondaparinux, rivaroxaban, and darexaban to be the most efficacious agents. […] The use of a checklist to stratify patients and assign them to categories of relative propensity for DVT development is helpful in deciding on an appropriate treatment regimen. […] In August 2024, updated European guidelines on perioperative prophylaxis of VTE in patients undergoing nonambulatory orthopedic surgery were published. […] Recommendations included the following: For patients undergoing low-VTE-risk procedures who do not have a personal high-risk factor for VTE, no pharmacologic VTE prophylaxis is suggested.

• #38 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention

  It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation (eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant), and intermittent pneumatic compression. Patients at higher risk of DVT include those undergoing minor surgery if they have clinical risk factors for DVT; those undergoing major surgery, especially orthopedic surgery, even without risk factors; and bedbound patients with major medical illnesses. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy (eg, compression devices or stockings, venous filters) and pharmacologic therapy (including low-dose unfractionated heparin, low molecular weight heparins, warfarin, fondaparinux, direct oral anticoagulants). The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The role of aspirin for DVT prophylaxis is largely limited to patients undergoing total hip or knee replacement surgery. Low-dose unfractionated heparin (UFH) is given 2 hours before surgery and every 8 to 12 hours thereafter for 7 to 10 days or until patients are fully ambulatory. LMWHs are more effective than low-dose UFH for preventing DVT and PE, but widespread use is limited by cost. Direct oral anticoagulants are at least as effective and safe as LMWH for preventing DVT and PE after hip or knee replacement surgery but are more expensive than warfarin. With DVT prophylaxis, there is always a risk of bleeding during use of anticoagulants. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment may be started before or after surgery and continued for at least 14 days. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.

• #39 Preventing deep vein thrombosis in hospital inpatients

  https://pmc.ncbi.nlm.nih.gov/articles/PMC1925160/

  Methods of DVT prophylaxis include general measures: the use of aspirin, mechanical prevention with graduated compression stockings, and intermittent pneumatic compression devices […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network support ambulation for all patients if possible, and recommend LMWH or UFH for medical patients with heart failure or respiratory disease or with substantial immobility plus additional risk factors for DVT […] Mechanical prophylaxis may be considered in all immobile patients and should be used for those who cannot receive anticoagulants […] Guidelines from the American College of Chest Physicians, the Institute for Clinical Systems Improvement, and the Scottish Intercollegiate Guidelines Network recommend early mobilisation for general surgery patients at low risk of DVT; UFH or LMWH for patients with risk factors for DVT (including age), and the addition of mechanical prophylaxis to LMWH or UFH for those with multiple risk factors for DVT

• #40 Appendix A: Tools and Resources | Agency for Healthcare Research and Quality

  https://www.ahrq.gov/patient-safety/settings/hospital/vtguide/appa.html

  Hospitalized patients are at high risk for venous thromboembolism (VTE). […] The high incidence of postoperative VTE and the availability of effective methods of prevention mandate that thromboprophylaxis be considered in every patient. […] Many medical patients are also at high risk. […] Effective, safe, and cost-effective measures to prevent hospital-associated VTE exist. […] Good evidence reveals that pharmacologic VTE prophylaxis for at-risk patients not only prevents adverse patient outcomes but also is cost effective. […] The high prevalence of hospital-associated VTE (HA-VTE) is sometimes due to the underutilization of simple, cost-effective prophylactic measures. […] The AHRQ report, Making Health Care Safer, cites the provision of VTE prophylaxis as the paramount effective strategy to improve patient safety, and a 2013 update continues to list improved prophylaxis for VTE as a top 10 patient safety strategy to act on now.

• #41 Venous Thromboembolism (VTE) | PM&R KnowledgeNow

  https://now.aapmr.org/venous-thromboembolism-vte/

  Most DVTs (90%) develop in the lower limbs. […] Only 33% of inpatients in US hospitals receive appropriate VTE prophylaxis. […] In a meta-analysis of hospitalized internal medicine patients, Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin (UFH) [5000 units subcutaneously three times daily] were found equally efficacious in preventing VTE, with similar risks of bleeding. […] The NCCN released guidelines in 2007 recommending VTE prophylaxis in all hospitalized cancer patients undergoing active therapy who do not have contraindications to anticoagulation. […] Joint replacement or major fracture patients, without a personal history of VTE, may have prophylaxis with mechanical prophylaxis plus one of the following: LMWH, fondaparinux, apixaban, dabigatran, rivaroxaban, low-dose unfractionated heparin (LDUH), adjusted-dose vitamin K antagonist or aspirin 325 mg twice daily for 10-14 days.

• #42 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  Based on thrombosis risk, patients are classified into low risk, moderate risk, and high risk for VTE. […] Commonly used pharmacological agents for prophylaxis in hospitalized patients are: Low-molecular-weight heparins (LMWH), Unfractionated heparin (UFH), Fondaparinux. […] Mechanical methods are used in patients with moderate-to-high risk for DVT with an increased risk of bleeding. […] The guidelines published by the National Comprehensive Cancer Network (NCCN), the American Society of Clinical Oncology (ASCO), and an international consensus group do not recommend routine VTE prophylaxis in ambulatory patients with cancer, except for those at very high risk of VTE. […] Long-distance travelers with risk factors for VTE can use properly fitted below-knee graduated compressive devices at 15 to 30 mm Hg of pressure, along with frequent ambulation and calf muscle exercises.

• #43 Patient education: Deep vein thrombosis (DVT) (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/deep-vein-thrombosis-dvt-beyond-the-basics

  DEEP VEIN THROMBOSIS PREVENTION […] People with cancer — In selected situations, such as in people undergoing treatment for cancer who are at high risk for DVT (eg, people with stomach or pancreatic cancer who are receiving chemotherapy), anticoagulants may be considered for use to prevent a DVT from occurring. […] During hospitalization — Some people who are in the hospital, either for surgery (especially bone or joint surgery and cancer surgery) or because of a serious medical illness, may be given anticoagulants to decrease the risk of blood clots. Anticoagulants may also be given to female patients at high risk for venous thrombosis during and after pregnancy. […] In people who are hospitalized and have a moderate to low risk of blood clots, other preventive measures may be used. For example, some people are fitted with inflatable compression devices after surgery. These devices are worn around the legs during and immediately after surgery and periodically fill with air. These devices apply gentle pressure to improve circulation and help prevent clots. Compression stockings may also be recommended.

• #44 Venous Thromboembolism (VTE) | PM&R KnowledgeNow

  https://now.aapmr.org/venous-thromboembolism-vte/

  Most DVTs (90%) develop in the lower limbs. […] Only 33% of inpatients in US hospitals receive appropriate VTE prophylaxis. […] In a meta-analysis of hospitalized internal medicine patients, Low Molecular Weight Heparin (LMWH) and Unfractionated Heparin (UFH) [5000 units subcutaneously three times daily] were found equally efficacious in preventing VTE, with similar risks of bleeding. […] The NCCN released guidelines in 2007 recommending VTE prophylaxis in all hospitalized cancer patients undergoing active therapy who do not have contraindications to anticoagulation. […] Joint replacement or major fracture patients, without a personal history of VTE, may have prophylaxis with mechanical prophylaxis plus one of the following: LMWH, fondaparinux, apixaban, dabigatran, rivaroxaban, low-dose unfractionated heparin (LDUH), adjusted-dose vitamin K antagonist or aspirin 325 mg twice daily for 10-14 days.

• #45 Prevention of Venous Thromboembolism | Doctor

  https://patient.info/doctor/prevention-of-venous-thromboembolism

  Consider pharmacological VTE prophylaxis for people with myeloma who are receiving chemotherapy with thalidomide, pomalidomide or lenalidomide with steroids. Choose either aspirin (75 mg or 150 mg) or LMWH. […] […] Consider pharmacological VTE prophylaxis with LMWH for people with pancreatic cancer who are receiving chemotherapy. […] […] If giving VTE prophylaxis to people with cancer, continue for as long as they are receiving chemotherapy. […] […] Consider pharmacological VTE prophylaxis for people who are having palliative care. Take into account temporary increases in thrombotic risk factors, risk of bleeding, likely life expectancy and the views of the person and their family members or carers. […] […] If risk of bleeding is low, consider intermittent pneumatic compression for VTE prophylaxis for people who are immobile and admitted with acute stroke. Start it within 3 days of acute stroke. […] […] LMWH is the prophylaxis of choice, being safer and equally effective as UFH. […]

• #46 Prevention of Venous Thromboembolism | Doctor

  https://patient.info/doctor/prevention-of-venous-thromboembolism

  Consider pharmacological VTE prophylaxis for people with myeloma who are receiving chemotherapy with thalidomide, pomalidomide or lenalidomide with steroids. Choose either aspirin (75 mg or 150 mg) or LMWH. […] […] Consider pharmacological VTE prophylaxis with LMWH for people with pancreatic cancer who are receiving chemotherapy. […] […] If giving VTE prophylaxis to people with cancer, continue for as long as they are receiving chemotherapy. […] […] Consider pharmacological VTE prophylaxis for people who are having palliative care. Take into account temporary increases in thrombotic risk factors, risk of bleeding, likely life expectancy and the views of the person and their family members or carers. […] […] If risk of bleeding is low, consider intermittent pneumatic compression for VTE prophylaxis for people who are immobile and admitted with acute stroke. Start it within 3 days of acute stroke. […] […] LMWH is the prophylaxis of choice, being safer and equally effective as UFH. […]

• #47 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  VTE risk is high in patients undergoing major orthopedic surgeries like knee or hip surgeries. […] Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] Pharmacological prophylaxis is considered in individual cases, particularly in those with the following risk factors: A prior history of VTE, Hospitalization for an acute illness or cesarean delivery, The presence of an inherited thrombophilia. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.

• #48 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  VTE risk is high in patients undergoing major orthopedic surgeries like knee or hip surgeries. […] Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] Pharmacological prophylaxis is considered in individual cases, particularly in those with the following risk factors: A prior history of VTE, Hospitalization for an acute illness or cesarean delivery, The presence of an inherited thrombophilia. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.

• #49 Venous Thromboembolism Prophylaxis in Obstetrics

  https://www.uspharmacist.com/article/venous-thromboembolism-prophylaxis-in-obstetrics

  Venous thromboembolism (VTE) is a complication of pregnancy that many providers find difficult to manage. […] However, appropriate VTE prophylaxis in high-risk mothers may be the key to preventing further complications, including myocardial infarction, paralysis, stroke, and death during or after delivery. […] The most vulnerable period for obstetric patients lies in the postpartum period, with an average 15- to 35-fold risk increase. […] The recommended prophylactic medications for both antepartum and postpartum are low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH), according to the American College of Obstetricians and Gynecologists (ACOG), and only LMWH is recommended by the Society of Obstetricians and Gynecologists of Canada. […] Prophylactic treatment is indicated when the risk of VTE is greater than the potential risks associated with complications and bleeding with either UFH or LMWH.

• #50 Venous Thromboembolism Prophylaxis in Obstetrics

  https://www.uspharmacist.com/article/venous-thromboembolism-prophylaxis-in-obstetrics

  Venous thromboembolism (VTE) is a complication of pregnancy that many providers find difficult to manage. […] However, appropriate VTE prophylaxis in high-risk mothers may be the key to preventing further complications, including myocardial infarction, paralysis, stroke, and death during or after delivery. […] The most vulnerable period for obstetric patients lies in the postpartum period, with an average 15- to 35-fold risk increase. […] The recommended prophylactic medications for both antepartum and postpartum are low-molecular-weight heparin (LMWH) and unfractionated heparin (UFH), according to the American College of Obstetricians and Gynecologists (ACOG), and only LMWH is recommended by the Society of Obstetricians and Gynecologists of Canada. […] Prophylactic treatment is indicated when the risk of VTE is greater than the potential risks associated with complications and bleeding with either UFH or LMWH.

• #51 Deep vein thrombosis – Wikipedia

  https://en.wikipedia.org/wiki/Deep_vein_thrombosis

  The risk of VTE is increased in pregnancy by about four to five times because of a more hypercoagulable state that protects against fatal postpartum hemorrhage. Preventive measures for pregnancy-related VTE were suggested by the American Society of Hematology in 2018. Warfarin, a common vitamin K antagonist, can cause birth defects and is not used for prevention during pregnancy. […] Suggestions for at-risk long-haul travelers include calf exercises, frequent walking, and aisle seating in airplanes to ease walking. Graduated compression stockings have sharply reduced the levels of asymptomatic DVT in airline passengers, but the effect on symptomatic DVT, PE, or mortality is unknown, as none of the individuals studied developed these outcomes. However, graduated compression stockings are not suggested for long-haul travelers (4 hours) without risk factors for VTE.

• #52 Venous Thromboembolism Prophylaxis in Obstetrics

  https://www.uspharmacist.com/article/venous-thromboembolism-prophylaxis-in-obstetrics

  In accordance with ACOG and the American College of Chest Physicians (ACCP), pharmacologic management is recommended in patients with a history of VTE in pregnancy or related to estrogen and in women with recurrent VTE. […] The postpartum period holds the most risk of VTE in obstetric patients. […] If traditional anticoagulation is recommended, medication must not be started before 4 to 6 hours postvaginal delivery and 6 to 12 hours post-cesarean to minimize bleeding complications associated with delivery. […] The role of a pharmacist in the prevention of VTE in obstetric patients lies mostly in the education on the risks associated with anticoagulant medications in women of childbearing age and obstetric patients. […] Identifying high-risk patients and carefully weighing the risks of coagulation and hemorrhage can be the key to decreasing the number of patients who experience VTE and subsequently the number of patients with complications of VTE including paralysis, stroke, myocardial infarction, and death.

• #53 Patient education: Deep vein thrombosis (DVT) (Beyond the Basics) – UpToDate

  https://www.uptodate.com/contents/deep-vein-thrombosis-dvt-beyond-the-basics

  In all cases, walking as soon as possible after surgery can decrease the risk of a blood clot; it can also decrease the risk of chronic swelling in the legs from your DVT (also known as „post-thrombotic syndrome”). […] Extended travel — Prolonged travel (eg, taking an airplane flight or car ride that lasts more than five hours) appears to increase the risk of developing blood clots, although the risk is very small. There are a few tips that may be of benefit during extended travel.

• #54 Deep Vein Thrombosis – Fit for Travel

  https://www.fitfortravel.nhs.uk/advice/general-travel-health-advice/deep-vein-thrombosis

  Long distance travel is a risk factor in the development of blood clots. […] Prolonged periods of immobility can lead to slow blood flow in the veins which increases the risk of developing a blood clot within a deep vein in the body; this is called deep vein thrombosis (DVT). […] Although the absolute risk of developing DVT or PE after a long haul flight is very small, the risk is increased if you have pre-existing risk factors. […] If you are at an increased risk of DVT or PE, anti-embolism stockings (AES) might be recommended to reduce your risk. […] Low molecular weight heparin can be considered for those at higher risk of developing DVT (see above).

• #55 Deep vein thrombosis (DVT) – Symptoms & causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/deep-vein-thrombosis/symptoms-causes/syc-20352557

  Lifestyle changes may help prevent deep vein thrombosis. Try these strategies: […] Move your legs. If you’ve had surgery or have been on bed rest, try to move as soon as possible. Don’t cross your legs while sitting. Doing so can block blood flow. […] When traveling, take frequent breaks to stretch your legs. When on a plane, stand or walk occasionally. If you’re traveling by car, stop every hour or so and walk around. If you can’t walk, do lower leg exercises. Raise and lower your heels while keeping your toes on the floor. Then raise your toes while keeping your heels on the floor. […] Don’t smoke. Smoking increases the risk of DVT. […] Manage weight. Obesity is a risk factor for DVT. Regular exercise lowers the risk of blood clots. As a general goal, aim for at least 30 minutes of moderate physical activity every day. If you want to lose weight, maintain weight loss or meet specific fitness goals, you may need to exercise more.

• #56 Prevention and Treatment of Venous Thromboembolism | American Heart Association

  https://www.heart.org/en/health-topics/venous-thromboembolism/prevention-and-treatment-of-venous-thromboembolism-vte

  Be proactive. Ask for a risk assessment for VTE if you are admitted to the hospital or are having surgery. […] VTEs often are preventable, with strategies that stop the development of clots in people „at-risk.” […] Those at risk may take anti-clotting, or blood-thinning, medications or use mechanical devices such as compression stockings or compression devices. […] Getting out of bed quickly after surgery is also advised if possible. […] Consider compression. Use graduated compression stockings or massaging compression devices if recommended by your health care professional. […] Take prescribed medication. If you have a high risk of a blood clot and a low risk of bleeding, a low-dose, “blood-thinning” medicine may help. […] Perform simple exercises. Flex and extend the ankles and knees and contract the calf muscles at regular intervals.

• #57 Deep Vein Thrombosis and Pulmonary Embolism | Yellow Book | CDC

  https://wwwnc.cdc.gov/travel/yellowbook/2024/air-land-sea/deep-vein-thrombosis-and-pulmonary-embolism

  The American College of Chest Physicians (ACCP) and the American Society of Hematology (ASH) each provide guidelines on the prevention of VTE in long-distance travelers. […] For long-distance travelers (6 hours travel) at increased risk of VTE, the ACCP recommends frequent ambulation, calf muscle exercise, sitting in an aisle seat, and using properly fitted below-the-knee GCS that provide 15-30 mmHg of pressure at the ankle during travel. […] For long-distance travelers (4 hours travel) at substantially increased VTE risk (e.g., recent surgery, prior history of VTE, postpartum, active malignancy, or 2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guidelines suggest GCS or prophylactic LMWH.

• #58 Deep vein thrombosis | Healthify

  https://healthify.nz/health-a-z/d/deep-vein-thrombosis/

  A DVT (deep vein thrombosis) is a blood clot that occurs in the deep veins. The most common veins to be affected are those in your legs. […] The main aim of DVT treatment is to prevent the clot from getting any bigger, and prevent it from breaking loose and causing a pulmonary embolism. […] Although DVT cannot be prevented in all situations, there are a few things you can do to lower your risk: Avoid sitting for long periods of time. Elevate (raise) your legs if you are sitting for moderate periods of time. […] Correctly fitted compression stockings can prevent DVT if you are at an increased risk. The slight pressure from the stocking helps to prevent blood pooling in the calf. […] If you are going to hospital to have an operation, your doctor will assess your risk of DVT. […] Depending on your risk factors and individual circumstances, your healthcare team will discuss treatment options with you. Treatment may include: wearing compression stockings, using a compression pump on your lower legs, taking tablets or injections (anticoagulant medication) to prevent a blood clot, gently exercising your feet and legs in bed, getting out of bed and walking as soon as possible. […] The following advice should be given to all people who are travelling long distances: Sitting in an aisle seat provides more opportunity for movement. Also consider exercising leg muscles while seated and walking whenever possible.

• #59 Deep Vein Thrombosis and Pulmonary Embolism | Yellow Book | CDC

  https://wwwnc.cdc.gov/travel/yellowbook/2024/air-land-sea/deep-vein-thrombosis-and-pulmonary-embolism

  The American College of Chest Physicians (ACCP) and the American Society of Hematology (ASH) each provide guidelines on the prevention of VTE in long-distance travelers. […] For long-distance travelers (6 hours travel) at increased risk of VTE, the ACCP recommends frequent ambulation, calf muscle exercise, sitting in an aisle seat, and using properly fitted below-the-knee GCS that provide 15-30 mmHg of pressure at the ankle during travel. […] For long-distance travelers (4 hours travel) at substantially increased VTE risk (e.g., recent surgery, prior history of VTE, postpartum, active malignancy, or 2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guidelines suggest GCS or prophylactic LMWH.

• #60 Deep Vein Thrombosis and Pulmonary Embolism | Yellow Book | CDC

  https://wwwnc.cdc.gov/travel/yellowbook/2024/air-land-sea/deep-vein-thrombosis-and-pulmonary-embolism

  The American College of Chest Physicians (ACCP) and the American Society of Hematology (ASH) each provide guidelines on the prevention of VTE in long-distance travelers. […] For long-distance travelers (6 hours travel) at increased risk of VTE, the ACCP recommends frequent ambulation, calf muscle exercise, sitting in an aisle seat, and using properly fitted below-the-knee GCS that provide 15-30 mmHg of pressure at the ankle during travel. […] For long-distance travelers (4 hours travel) at substantially increased VTE risk (e.g., recent surgery, prior history of VTE, postpartum, active malignancy, or 2 risk factors, including combinations of the above with hormone replacement therapy, obesity, or pregnancy), the ASH guidelines suggest GCS or prophylactic LMWH.

• #61 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  VTE risk is high in patients undergoing major orthopedic surgeries like knee or hip surgeries. […] Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] Pharmacological prophylaxis is considered in individual cases, particularly in those with the following risk factors: A prior history of VTE, Hospitalization for an acute illness or cesarean delivery, The presence of an inherited thrombophilia. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.

• #62 Deep Venous Thrombosis Prophylaxis | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/20299

  Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] Patients undergoing isolated lower extremity orthopedic surgery requiring immobilization do not require DVT prophylaxis as long as they can ambulate early and adequately. […] Major surgeries are categorized as moderate to high risk for VTE and need DVT prophylaxis. […] Antepartum pharmacological prophylaxis is continued throughout the pregnancy. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] The complications from pharmacological prophylaxis include: Disturbed renal function, Bleeding, Heparin-induced thrombocytopenia (HIT). […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients.

• #63 Venous Thromboembolism Prevention Clinical Care Standard | Australian Commission on Safety and Quality in Health Care

  https://www.safetyandquality.gov.au/standards/clinical-care-standards/venous-thromboembolism-prevention-clinical-care-standard

  Despite current efforts, evidence suggests that a large proportion of hospitalised patients are at risk of VTE, however many patients do not receive appropriate VTE prophylaxis. […] VTE prevention strategies have been shown to significantly reduce the incidence of VTE by about 70%. […] Hospitalisation is a major risk factor for VTE, with about 74% of VTE cases occurring up to three months after hospital discharge. […] The development of the Venous Thromboembolism Prevention Clinical Care Standard was proposed by states and territory health departments as a way of improving the uptake of appropriate VTE prophylaxis strategies.

• #64 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism

  https://www.outcomes-umassmed.org/dvt/best_practice/

  For over a decade, we have been involved in projects to improve the use of prophylaxis for deep vein thrombosis (DVT) in Massachusetts hospitals. […] The tools provided in this manual will help you to create a structured quality improvement program that can assist physicians and hospital quality assurance managers in evaluating and improving the use of DVT prophylaxis. […] Implementation of a system-wide process for preventing DVT will also help your hospital meet the JCAHO requirement for quality improvement activities. […] Each year, 600,000 patients will experience venous thromboembolism. […] Use of modern methods of DVT prophylaxis will reduce the incidence of DVT during the postoperative period by two-thirds and will prevent death from pulmonary embolism in 1 patient out of every 200 major operations.

• #65 The Johns Hopkins Venous Thromboembolism (VTE) Collaborative Studies and Implements Methods to Prevent Avoidable Cases of Hospital Associated VTE | PSNet

  https://psnet.ahrq.gov/innovation/johns-hopkins-venous-thromboembolism-vte-collaborative-studies-and-implements-methods

  Missed doses of prescribed VTE prophylaxis were also found to be a cause of preventable harm. […] The VTE Collaborative identified two barriers to medication administration that required improvement: nursing knowledge and patient refusal. […] In a retrospective cohort study of 1,599 patients, prescriber compliance with guideline-appropriate prophylaxis increased from 66.2% to 84.4% after the implementation of a computerized clinical decision support tool. […] A pre-post analysis of 1,614 patient visits examining missed doses of VTE prophylaxis in a community hospital found that when a patient-centered education bundle was used, the proportion of any missed dose decreased significantly from 13.8% to 8.2%.

• #66 The Johns Hopkins Venous Thromboembolism (VTE) Collaborative Studies and Implements Methods to Prevent Avoidable Cases of Hospital Associated VTE | PSNet

  https://psnet.ahrq.gov/innovation/johns-hopkins-venous-thromboembolism-vte-collaborative-studies-and-implements-methods

  Missed doses of prescribed VTE prophylaxis were also found to be a cause of preventable harm. […] The VTE Collaborative identified two barriers to medication administration that required improvement: nursing knowledge and patient refusal. […] In a retrospective cohort study of 1,599 patients, prescriber compliance with guideline-appropriate prophylaxis increased from 66.2% to 84.4% after the implementation of a computerized clinical decision support tool. […] A pre-post analysis of 1,614 patient visits examining missed doses of VTE prophylaxis in a community hospital found that when a patient-centered education bundle was used, the proportion of any missed dose decreased significantly from 13.8% to 8.2%.

• #67 Deep Venous Thrombosis Prophylaxis (DVT Prophylaxis) – MD Searchlight

  https://mdsearchlight.com/preventive-medicine/deep-venous-thrombosis-prophylaxis-dvt-prophylaxis/

  Deep vein thrombosis (DVT) is the medical term for a blood clot that forms in the deeper veins of your body, mostly in the legs. Preventing DVT is important because it can stop PE, which can be very severe and even lethal. DVT is a major cause of illness and death that can be avoided globally. In the United States, DVT and PE cause between 60,000 and 100,000 deaths every year. Patients in the hospital are at higher risk of getting DVT as they often have to stay still for long periods, and for other reasons. Thats why doctors often provide these patients with DVT prophylaxis treatments to help prevent DVT. There are two main ways to do this: mechanical methods that help blood flow better, and drugs that make your blood less prone to clotting. Providing these treatments to patients in the hospital can significantly reduce the chances of DVT and PE, leading to better patient outcomes overall. This prevention can either be primary (preferred), which uses medications and mechanical methods to avoid DVT from happening, or secondary, which is less common and involves early detection and treatment when DVT has already begun, but is not yet causing symptoms. Proactive measures to prevent these clots, or deep vein thrombosis (DVT) prophylaxis, should be considered for every patient staying in a hospital. To decide the best preventive measures, patients at risk of developing clots (thrombosis) are categorized into three groups: Low-risk patients: Young individuals without any risk factors for clot formation. They usually dont need preventive measures. Moderate-risk patients: Patients with at least one risk factor. Regular medication, sometimes combined with mechanical preventive measures, is often recommended to prevent clot formation. High-risk patients: Patients with several risk factors. Medication in combination with mechanical measures is the preferred preventive option. Various drugs are commonly used to prevent clots in hospitalized patients and include low-molecular-weight heparins (LMWH), unfractionated heparin (UFH), and fondaparinux. Direct oral anticoagulants, a new type of blood thinner, have also been shown to reduce death rates among hospitalized patients, with betrixaban and rivaroxaban being approved for use in the hospital setting. Patients deemed at risk for developing clots yet also at high risk for bleeding may require mechanical measures, which include the use of devices like intermittent pneumatic compression, graduated compression stockings, and venous foot pump. Long-distance travelers who have a risk of VTE are recommended to wear properly fitted, below-knee compression stockings that apply 15-30 mm Hg of pressure. They are also advised to regularly stand and move around during the trip. A person should not get Deep Venous Thrombosis (DVT) prophylaxis if they are currently bleeding, have a blood clotting disorder, are scheduled for surgery in the next 6 to 12 hours, have low blood platelets, have a bleeding disorder, have peripheral vascular disease, or have broken down and non-healable skin. Taking preventative medicines can sometimes lead to side effects, including disturbed kidney function, bleeding, and heparin-induced thrombocytopenia (HIT). DVT prophylaxis can decrease the chances of getting DVT by 10 to 80%.

• #68 Venous Thromboembolism: Low Dose Heparin for DVT/PE Prophylaxis

  https://www.east.org/education-resources/practice-management-guidelines/details/venous-thromboembolism–low-dose-heparin-for-dvt-pe-prophylaxis

  The fact that DVT and pulmonary embolism (PE) occur after trauma is incontrovertible. The optimal mode of prophylaxis has yet to be determined. Low-dose heparin (LDH), given in doses of 5,000 units subcutaneously two or three times daily, represents one pharmacologic treatment modality for prophylaxis against DVT/PE. […] Little evidence exists to support the benefit of LDH as a sole agent for prophylaxis in the trauma patient at high-risk for VTE. […] For patients in whom bleeding could exacerbate injuries (such as those with intracranial hemorrhage, incomplete spinal cord injuries, intraocular injuries, severe pelvic or lower extremity injuries with traumatic hemorrhage, and intra-abdominal solid organ injuries being managed nonoperatively), the safety of LDH has not been established, and an individual decision should be made when considering anticoagulant prophylaxis.

• #69 Deep Vein Thrombosis – Zero To Finals

  https://zerotofinals.com/surgery/vascular/dvt/

  There are several factors that can put patients at higher risk of developing a DVT or PE. In many of these situations (e.g., surgery), we give patients prophylactic treatment to prevent VTE. […] Every patient admitted to hospital should be assessed for their risk of venous thromboembolism (VTE). If they are at increased risk of VTE, they should receive prophylaxis unless contraindicated. Prophylaxis is usually with low molecular weight heparin, such as enoxaparin. Contraindications include active bleeding or existing anticoagulation with warfarin or a DOAC. […] Anti-embolic compression stockings are also used, unless contraindicated. The main contraindication for compression stockings is significant peripheral arterial disease.

• #70 Deep Venous Thrombosis (DVT) Prevention – Cardiovascular Disorders – Merck Manual Professional Edition

  https://www.merckmanuals.com/professional/cardiovascular-disorders/peripheral-venous-disorders/deep-venous-thrombosis-dvt-prevention

  It is preferable and safer to prevent deep venous thrombosis (DVT) than to treat it, particularly in patients who are at high risk. DVT prophylaxis begins with risk assessment. Preventive measures include prevention of immobility, prophylactic anticoagulation (eg, low molecular weight heparin, fondaparinux, adjusted-dose warfarin, direct oral anticoagulant), and intermittent pneumatic compression. Patients at higher risk of DVT include those undergoing minor surgery if they have clinical risk factors for DVT; those undergoing major surgery, especially orthopedic surgery, even without risk factors; and bedbound patients with major medical illnesses. Most of these patients can be identified and should receive DVT prophylaxis. DVT prophylaxis can involve one or more of the following: mechanical therapy (eg, compression devices or stockings, venous filters) and pharmacologic therapy (including low-dose unfractionated heparin, low molecular weight heparins, warfarin, fondaparinux, direct oral anticoagulants). The benefit of graded compression stockings is questionable except for low-risk surgical patients and selected hospitalized medical patients. However, combining stockings with other preventive measures may be more protective than any single approach. For patients who are at very high risk of DVT and bleeding, IPC is recommended until the bleeding risk subsides and anticoagulants can be given. The role of aspirin for DVT prophylaxis is largely limited to patients undergoing total hip or knee replacement surgery. Low-dose unfractionated heparin (UFH) is given 2 hours before surgery and every 8 to 12 hours thereafter for 7 to 10 days or until patients are fully ambulatory. LMWHs are more effective than low-dose UFH for preventing DVT and PE, but widespread use is limited by cost. Direct oral anticoagulants are at least as effective and safe as LMWH for preventing DVT and PE after hip or knee replacement surgery but are more expensive than warfarin. With DVT prophylaxis, there is always a risk of bleeding during use of anticoagulants. For hip and other lower extremity orthopedic surgery, selected direct oral anticoagulants, LMWH, fondaparinux, or adjusted-dose warfarin is recommended. Preventive treatment may be started before or after surgery and continued for at least 14 days. Preventive treatment is also indicated for patients who have major medical illnesses that require bed rest. Low-dose UFH or LMWH is effective in patients who are not already receiving IV heparin or thrombolytics; IPC, elastic stockings, or both may be used when anticoagulants are contraindicated. In patients with symptomatic DVT who develop symptoms of post-thrombotic syndrome, the use of knee-high compression stockings providing 30 to 40 mm Hg pressure is recommended. Treatment to prevent deep venous thrombosis is required for patients who are bedbound with major illness and/or those undergoing certain surgical procedures. Early mobilization, leg elevation, and an anticoagulant are the recommended preventive measures; patients who should not receive anticoagulants may benefit from intermittent pneumatic compression devices or elastic stockings.

• #71 Deep Venous Thrombosis Prophylaxis | Treatment & Management | Point of Care

  https://www.statpearls.com/point-of-care/20299

  Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] Patients undergoing isolated lower extremity orthopedic surgery requiring immobilization do not require DVT prophylaxis as long as they can ambulate early and adequately. […] Major surgeries are categorized as moderate to high risk for VTE and need DVT prophylaxis. […] Antepartum pharmacological prophylaxis is continued throughout the pregnancy. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] The complications from pharmacological prophylaxis include: Disturbed renal function, Bleeding, Heparin-induced thrombocytopenia (HIT). […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients.

• #72 Venous Thromboembolism: Management Guidelines from the American Society of Hematology | AAFP

  https://www.aafp.org/pubs/afp/issues/2021/1000/p429.html

  In-hospital and home treatment of PE provide similar outcomes, although home treatment of DVT produces better outcomes. […] After primary DOAC treatment for three to six months, decisions for indefinite anticoagulation depend on risk factors associated with initial VTE. […] When VTE is unprovoked or associated with chronic factors, indefinite anticoagulation reduces recurrent VTE with a slightly increased risk of major bleeding. […] After primary treatment, secondary VTE prevention is recommended for patients with a chronic persistent risk factor without a high risk of bleeding complications. […] After VTE that is unprovoked or provoked by a chronic factor, indefinite anticoagulation should be considered. […] For unprovoked VTE, indefinite anticoagulation with a DOAC reduces recurrent PE and DVT, although with an increase in major bleeding.

• #73 Deep Venous Thrombosis Prophylaxis – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK534865/

  VTE risk is high in patients undergoing major orthopedic surgeries like knee or hip surgeries. […] Duration: At least 10 to 14 days, preferably 35 days from the day of surgery (especially for patients undergoing total hip arthroplasty) in the absence of risk factors for bleeding. […] The incidence of venous thromboembolism is increased during or trimester of pregnancy and is highest during the postpartum period. […] Pharmacological prophylaxis is considered in individual cases, particularly in those with the following risk factors: A prior history of VTE, Hospitalization for an acute illness or cesarean delivery, The presence of an inherited thrombophilia. […] DVT increases the risk of pulmonary embolism by 50% and also leads to post-thrombotic syndrome. Using DVT prophylaxis in hospitalized patients decreases the risk of DVT anywhere from 10 to 80%. […] Interprofessional teamwork is essential in preventing DVT in hospitalized patients. Good interprofessional communication among attending clinicians, surgeons (for surgical patients), nursing staff, and pharmacists is vital in using the appropriate prophylaxis methods.

• #74 Venous Thromboembolism Prophylaxis in Obstetrics

  https://www.uspharmacist.com/article/venous-thromboembolism-prophylaxis-in-obstetrics

  In accordance with ACOG and the American College of Chest Physicians (ACCP), pharmacologic management is recommended in patients with a history of VTE in pregnancy or related to estrogen and in women with recurrent VTE. […] The postpartum period holds the most risk of VTE in obstetric patients. […] If traditional anticoagulation is recommended, medication must not be started before 4 to 6 hours postvaginal delivery and 6 to 12 hours post-cesarean to minimize bleeding complications associated with delivery. […] The role of a pharmacist in the prevention of VTE in obstetric patients lies mostly in the education on the risks associated with anticoagulant medications in women of childbearing age and obstetric patients. […] Identifying high-risk patients and carefully weighing the risks of coagulation and hemorrhage can be the key to decreasing the number of patients who experience VTE and subsequently the number of patients with complications of VTE including paralysis, stroke, myocardial infarction, and death.

• #75

  https://www.aorn.org/article/key-takeaways-6-critical-guideline-updates-to-prevent-vte

  The updated AORN Guideline for Prevention of Venous Thromboembolism (VTE) provides recommendations on creating and implementing a protocol to prevent VTE, including deep vein thrombosis (DVT), via mechanical and pharmacologic prophylaxis. […] DVTs can travel to the lungs, becoming a life-threatening pulmonary embolism. […] The benefit of nurse-initiated mechanical VTE prophylaxis with intermittent pneumatic compression (IPC) likely outweighs the risk of no mechanical prophylaxis in surgical patients at risk for VTE. […] Initiating the VTE risk assessment before the day of surgery allows the patient to participate. […] Using a standardized VTE risk assessment tool facilitates improved accuracy of VTE risk assessment, promotes adherence to VTE prophylaxis according to a stratified risk profile, and supports communication among team members using a standardized understanding of VTE risk.

• #76

  https://www.aorn.org/article/key-takeaways-6-critical-guideline-updates-to-prevent-vte

  Heparin-based medications can have animal origins and can be of concern to some patients because of their religious or cultural beliefs. […] Foot and ankle exercises should not be a replacement for early and frequent postoperative ambulation. […] Providing preoperative education with a VTE pamphlet in presurgical testing increased patient knowledge of VTE and use of postoperative mechanical prophylaxis. […] A nurse-led preoperative patient DVT training session using a guidebook was found to increase the level of patient knowledge about DVT and the frequency of performing postoperative DVT self-care practices.

• #77

  https://www.aorn.org/article/key-takeaways-6-critical-guideline-updates-to-prevent-vte

  Heparin-based medications can have animal origins and can be of concern to some patients because of their religious or cultural beliefs. […] Foot and ankle exercises should not be a replacement for early and frequent postoperative ambulation. […] Providing preoperative education with a VTE pamphlet in presurgical testing increased patient knowledge of VTE and use of postoperative mechanical prophylaxis. […] A nurse-led preoperative patient DVT training session using a guidebook was found to increase the level of patient knowledge about DVT and the frequency of performing postoperative DVT self-care practices.

• #78 Prevention of Deep Vein Thrombosis | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/deep-vein-thrombosis/treatments/prevention.html

  Preventing deep vein thrombosis is important to prevent pulmonary embolism, which can lead to serious complications. […] Medications, such as anticoagulants, may be given to certain surgical patients to prevent deep vein thrombosis. Those patients who have had a previous clot should follow the instructions of their physician. […] Preventing deep vein thrombosis caused by long periods of sitting or reclining involves moving the lower leg. Flexing (bending) the knees may be helpful. […] Other preventative measures may include: […] Getting up and moving as soon as possible after surgery or illness, as movement can help to prevent clots from forming by stimulating blood circulation […] A pneumatic compression device, which looks like a special fitted sleeve, placed on the legs to help keep blood moving during some types of surgery […] Elastic stockings to reduce swelling and promote circulation.

• #79 Best Practices Preventing Deep Vein Thrombosis and Pulmonary Embolism

  https://www.outcomes-umassmed.org/dvt/best_practice/

  Using prophylaxis for DVT is neither complicated nor expensive. […] The approach to DVT prevention is similar to preventing postoperative wound infections. […] The keys to preventing DVT are in knowing who is at risk, when to apply the preventive measure, and applying the appropriate measure. […] It is estimated that one in 100 patients admitted to a hospital dies because of PE. […] It appears possible than more than one-half of these at-risk patients could be saved if effective prophylaxis was used. […] In more than 90 percent of cases of PE, the thrombosis originates in the deep veins of the legs. […] Deep vein thrombosis (DVT) is itself a distressing but often avoidable condition that leads to long-term complications such as the post-phlebitic syndrome and chronic leg ulcers in a large proportion of patients who have proximal vein thrombosis.

• #80 Venous Thromboembolism Prevention Clinical Care Standard | Australian Commission on Safety and Quality in Health Care

  https://www.safetyandquality.gov.au/standards/clinical-care-standards/venous-thromboembolism-prevention-clinical-care-standard

  Implementing clinical care standards helps health service organisations to meet the requirements of the National Safety and Quality Health Service (NSQHS) Standards for accreditation. […] The Commission has developed a guide to support the implementation of the Venous Thromboembolism Prevention Clinical Care Standard. […] A patient potentially at risk of VTE (as determined by local hospital/unit policy) receives a timely assessment of VTE risk using a locally endorsed evidence-based tool to determine their need for VTE prevention. […] A patient assessed to be at risk of VTE has a prevention plan developed that balances the risk of thrombosis against the risk and consequences of bleeding (as an adverse effect of VTE prevention medicines). […] A patient at risk of VTE receives information and education about VTE and ways to prevent it tailored to their risks and needs, and shares in decisions regarding their VTE prevention plan.

• #81 Preventing deep vein thrombosis in hospital inpatients

  https://pmc.ncbi.nlm.nih.gov/articles/PMC1925160/

  NICE recommends mechanical prophylaxis for all patients, with the addition of LMWH for those with one or more risk factors for DVT […] Appropriate use of DVT prophylaxis in hospital inpatients is important for reducing the risk of post-thrombotic complications as well as fatal and non-fatal pulmonary embolism […] For patients at low risk of DVT, ambulation is important, and mechanical methods of prophylaxis can provide added protection […] Patients at higher risk of DVT should be considered for guideline based anticoagulation with LMWH, UFH, or vitamin K antagonists unless clearly contraindicated […] The place of aspirin in DVT prophylaxis remains controversial.

• #82 Venous Thromboembolism Prevention Clinical Care Standard | Australian Commission on Safety and Quality in Health Care

  https://www.safetyandquality.gov.au/standards/clinical-care-standards/venous-thromboembolism-prevention-clinical-care-standard

  Despite current efforts, evidence suggests that a large proportion of hospitalised patients are at risk of VTE, however many patients do not receive appropriate VTE prophylaxis. […] VTE prevention strategies have been shown to significantly reduce the incidence of VTE by about 70%. […] Hospitalisation is a major risk factor for VTE, with about 74% of VTE cases occurring up to three months after hospital discharge. […] The development of the Venous Thromboembolism Prevention Clinical Care Standard was proposed by states and territory health departments as a way of improving the uptake of appropriate VTE prophylaxis strategies.

Zobacz więcej